US EditionModified FLOT Beats FOLFOX for Advanced Gastric Cancer
Summary by MedPage Today
1 Articles
1 Articles
All
Left
Center
1
Right
Modified FLOT Beats FOLFOX for Advanced Gastric Cancer
(MedPage Today) -- A modified FLOT regimen (fluorouracil, oxaliplatin, and docetaxel; TFOX) outperformed a standard chemotherapy triplet for the first-line treatment of advanced HER2-negative gastric cancer, a phase III trial showed. In the more...
·New York, United States
Read Full ArticleCoverage Details
Total News Sources1
Leaning Left0Leaning Right0Center1Last UpdatedBias Distribution100% Center
Bias Distribution
- 100% of the sources are Center
100% Center
C 100%
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
